A European non-interventional study to understand the criteria used and the time required for the clinical diagnosis in participants with refractory epilepsies associated with developmental delay European Non-interventional Study on Refractory Epilepsy with Developmental Delay (ENSURED)

Study identification

• EU PAS number:
  EUPAS32984
• Study ID:
  32985
• Official title and acronym:
  A European non-interventional study to understand the criteria used and the time required for the clinical diagnosis in participants with refractory epilepsies associated with developmental delay European Non-interventional Study on Refractory Epilepsy with Developmental Delay (ENSURED)
• DARWIN EU® study:
  No
• Study countries:
  Belgium

  France

  Germany

  Ireland

  Italy

  Spain

  Sweden

  United Kingdom
• Study description:
  No information provided.
• Study status:
  Planned

Research institutions and networks

Institutions

Zogenix International

Study timelines

Date when funding contract was signed

Actual:18/12/2019

Study start date

Planned:01/01/2020

Date of final study report

Planned:31/12/2020

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Zogenix International Ltd.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable